126 related articles for article (PubMed ID: 2338124)
1. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.
Bito LZ; Miranda OC; Tendler MR; Resul B
Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124
[TBL] [Abstract][Full Text] [Related]
2. Eicosanoids as a new class of ocular hypotensive agents. 1. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F and D type.
Bito LZ; Baroody RA; Miranda OC
Exp Eye Res; 1987 Jun; 44(6):825-37. PubMed ID: 3653276
[TBL] [Abstract][Full Text] [Related]
3. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.
Hayashi M; Yablonski ME; Bito LZ
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1639-43. PubMed ID: 3654137
[TBL] [Abstract][Full Text] [Related]
4. Effects of prostaglandins F2 alpha, A2, and their esters in glaucomatous monkey eyes.
Wang RF; Camras CB; Lee PY; Podos SM; Bito LZ
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2466-70. PubMed ID: 2243010
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical prostaglandin PGA2, PGA2 isopropyl ester, and PGF2 alpha isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes.
Gum GG; Kingsbury S; Whitley RD; Garcia A; Gelatt KN
J Ocul Pharmacol; 1991; 7(2):107-16. PubMed ID: 1919268
[TBL] [Abstract][Full Text] [Related]
6. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ
Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
[TBL] [Abstract][Full Text] [Related]
7. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
[TBL] [Abstract][Full Text] [Related]
8. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.
Bito LZ; Draga A; Blanco J; Camras CB
Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617
[TBL] [Abstract][Full Text] [Related]
9. PGF2 alpha/pilocarpine interactions on IOP and accommodation in monkeys.
Millar JC; Kaufman PL
Exp Eye Res; 1995 Dec; 61(6):677-83. PubMed ID: 8846839
[TBL] [Abstract][Full Text] [Related]
10. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
Bito LZ; Baroody RA
Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.
Bito LZ
Exp Eye Res; 1984 Feb; 38(2):181-94. PubMed ID: 6370708
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes.
Groeneboer MC; Hoyng PF; Kuizenga A
Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937
[TBL] [Abstract][Full Text] [Related]
13. Effects of topically applied PGF2 alpha and its isopropylester on normal and glaucomatous human eyes.
Alm A; Villumsen J
Prog Clin Biol Res; 1989; 312():447-58. PubMed ID: 2678150
[TBL] [Abstract][Full Text] [Related]
14. Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes.
Villumsen J; Alm A
Acta Ophthalmol (Copenh); 1990 Jun; 68(3):341-3. PubMed ID: 2392914
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes.
Stern FA; Bito LZ
Invest Ophthalmol Vis Sci; 1982 May; 22(5):588-98. PubMed ID: 7076404
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical studies with prostaglandins and their analogues.
Camras CB; Alm A
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
[TBL] [Abstract][Full Text] [Related]
17. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects.
Lee PY; Shao H; Xu LA; Qu CK
Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1474-7. PubMed ID: 3170119
[TBL] [Abstract][Full Text] [Related]
18. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes.
Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N
Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756
[TBL] [Abstract][Full Text] [Related]
19. Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2 alpha.
Camras CB; Bito LZ
Curr Eye Res; 1981; 1(4):205-9. PubMed ID: 6949676
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
Goh Y; Nakajima M; Azuma I; Hayaishi O
Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
